SECsense Logo

Vertex Pharmaceuticals Inc. 8-K Report: Key Updates as of May 5, 2025

$VRTX
Form 8-K
Filed on: 2025-05-05
Source
Vertex Pharmaceuticals Inc. 8-K Report: Key Updates as of May 5, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Name: Vertex Pharmaceuticals Inc.
  • Location: 50 Northern Avenue, Boston, MA 02210
  • Phone Number: 617-341-6100
  • CIK: 0000875320
  • SEC File Number: 000-19319
  1. Filing Type:
  • Form: 8-K (Current Report)
  1. Filing Date:
  • Date of Filing: May 5, 2025
  1. Stock Information:
  • Stock Type: Common Stock
  • Par Value: $0.01 per share
  • Ticker Symbol: VRTX
  • Exchange: NASDAQ
  1. Period of Report:
  • Reporting Date: May 5, 2025
  • The report is effective for a single day, which is typical for an 8-K filing.

Overall, this section indicates that Vertex Pharmaceuticals Inc. filed a current report (8-K) with the SEC, providing updates or information relevant to investors as of May 5, 2025. The mention of common stock with a par value provides context on the company's equity structure.